Lv3
390 积分 2025-11-14 加入
Tumour heterogeneity and resistance to cancer therapies
13小时前
待确认
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
6天前
已完结
Alternative splicing: a bridge connecting NAFLD and HCC
6天前
已完结
NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
6天前
已完结
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
6天前
已完结
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
6天前
已完结
Global epidemiology of cirrhosis — aetiology, trends and predictions
6天前
已完结
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity
18天前
已完结
Liver organoid as a 3D in vitro model for drug validation and toxicity assessment
18天前
已完结
An aptamer-based drug delivery agent (CD133-apt-Dox) selectively and effectively kills liver cancer stem-like cells
18天前
已完结
皖公网安备34019202002308
